Posted On: 01/15/2014 9:12:21 AM
Post# of 145151
$PLPL Plandaí subsidiary, Cannabis Biosciences, Inc., will be developing and testing a botanical extract derived from cannabis, and the company its marijuana research will address neural disorders with. Specifically, the company believes that the phytonutrients in cannabis show excellent potential for treating and preventing a host of neuron and injury related brain diseases including Parkinson's, Alzheimer's, ALS, MS, epilepsy, PTSD and post-concussion syndrome http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U
(0)
(0)
